Skip to content

Effect of Vasuvaasi Chooranam in patients with Bronchial Asthma (Swasakasam)

A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON-RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF VASUVAASI CHOORANAM IN THE MANAGEMENT OF SWASAKASAM (BRONCHIAL ASTHMA) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104878
Enrollment
40
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Vasuvaasi chooranam: Dosage:1 gram thrice a day for 40 days Control Intervention1: NIL: NIL

Sponsors

Government Siddha Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adults who are diagnosed with bronchial asthma 2.Patients with a clinical symptoms of swasakasam-recurrent episodes of wheezing, chest tightness, shortness of breath and dry cough, worse at night or early morning 3.History of symptoms triggered by allergens, climatic changes 4.Patients willing to provide blood samples for laboratory investigations

Exclusion criteria

Exclusion criteria: 1.Patients with pulmonary Tuberculosis 2.Patients with status asthmaticus 3.Patients with chronic bronchitis, chronic bronchiectasis 4.Patients with heart failure 5.Patients with renal disease 6.Pregnancy and Lactating mothers 7.Diabetes mellitus 8.Hypertension

Design outcomes

Primary

MeasureTime frame
Reduction in the severity and frequency of clinical symptoms of Swasakasam (Bronchial Asthma), including shortness of breath, chest tightness, wheezing, and dry cough Timepoint: 40 days

Secondary

MeasureTime frame
1.Evaluation of Asthma Control Questionnaire (ACQ) score following treatment 2.Evalaution of absolute eosinophil count following treatment 3.Evaluation of peak expiratory flow rate (PEFR) following treatmentTimepoint: 6 months

Countries

India

Contacts

Public ContactDR S JUSTUS ANTONY

Government Siddha Medical College and Hospital, Palayamkottai

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026